Sukhtian Faisal Ghiath Insider Trading Activity

Average Profitability
121.5%
Insider Buys Quantity
4
Insider Buys Sum
$95,562.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sukhtian Faisal Ghiath

According to the SEC Form 4 filings, Sukhtian Faisal Ghiath, being in a position of

  1. director at Outlook Therapeutics, Inc.,
    оver the last 12 months, has bought 217572 shares for $150,002, and sold 0 shares,
    over all time since 2020-09-17, has bought 295572 shares for $245,564, and sold 0 shares.

Biography of Sukhtian Faisal Ghiath

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $150,0022100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-07-29PurchaseOutlook Therapeutics, Inc.
OTLK
director
95,398
0.2431%
$1.05$99,996-36.02%
2026-05-27PurchaseOutlook Therapeutics, Inc.
OTLK
director
122,174
0.2076%
$0.41$50,006+19.56%
2022-10-07PurchaseOutlook Therapeutics, Inc.
OTLK
director
30,000
0.0135%
$1.29$38,700-9.92%
2021-12-02PurchaseOutlook Therapeutics, Inc.
OTLK
director
18,000
0.0097%
$1.40$25,200-9.42%
2021-04-19PurchaseOutlook Therapeutics, Inc.
OTLK
director
10,000
0.0059%
$1.82$18,200+14.21%
2020-09-17PurchaseOutlook Therapeutics, Inc.
OTLK
director
20,000
0.0225%
$0.67$13,462+228.79%
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.